Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide

Am J Ophthalmol. 2006 Mar;141(3):580-2. doi: 10.1016/j.ajo.2005.10.004.


Purpose: To report a case of severe corticosteroid-induced glaucoma after intravitreal injection of triamcinolone acetate in a 34-year-old man without a history of glaucoma.

Design: Observational case report.

Methods: Retrospective review of a clinical case.

Results: A 34-year-old man acquired visual field defects and severe vision loss in both eyes after intravitreal injection of triamcinolone for diabetic macular edema.

Conclusions: Intravitreal injection of triamcinolone is a commonly performed treatment for many retinal conditions. This treatment has the potential to cause severe vision loss as a result of intractable corticosteroid-induced glaucoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antihypertensive Agents / therapeutic use
  • Diabetic Retinopathy / drug therapy
  • Fluorescein Angiography
  • Glaucoma / chemically induced*
  • Glaucoma / drug therapy
  • Glucocorticoids / adverse effects*
  • Humans
  • Injections
  • Intraocular Pressure
  • Macular Edema / drug therapy
  • Male
  • Retrospective Studies
  • Triamcinolone Acetonide / adverse effects*
  • Vision Disorders / chemically induced
  • Visual Fields / drug effects
  • Vitreous Body


  • Antihypertensive Agents
  • Glucocorticoids
  • Triamcinolone Acetonide